http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105012323-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_563a6491fb068309bbf190a278715fcb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2014-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eee0f8149736abef16b6be47343fd07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20e20e2b872cd3818abf01b4f1f2347f |
| publicationDate | 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105012323-A |
| titleOfInvention | Intervention of bilobalide B to early cerebral ischemia-reperfusion injuries of animals with abnormal glucose tolerance |
| abstract | The invention relates to a medicine for treating cerebral ischemia-reperfusion injuries. The medicine comprises the active component bilobalide B. The medicine for treating the cerebral ischemia-reperfusion injuries has a certain treatment effect on the cerebral ischemia-reperfusion injuries. The invention provides a probable medicine with treatment and protection effects on a cerebral ischemia-reperfusion injury phase of an abnormal glucose tolerance stage. The compound provided by the invention shows a high effect of resisting ischemia and reperfusion injuries on a multi-step blocking effect in the pathological processes of ischemia and reperfusion injuries through multi-target action, has a better treatment effect in comparison with a medicine with a single action mechanism, and has certain guiding significance on clinical medication. |
| priorityDate | 2014-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.